138 related articles for article (PubMed ID: 9248872)
1. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
[TBL] [Abstract][Full Text] [Related]
2. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
[TBL] [Abstract][Full Text] [Related]
3. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Masica AL; Mayo G; Wilkinson GR
Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
[TBL] [Abstract][Full Text] [Related]
4. No correlations between the urinary ratio of 6beta-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam.
Yasui-Furukori N; Kondo T; Kubota T; Otake H; Ohkubo T; Nagasaki T; Sugawara K; Chiba K; Otani K; Kaneko S
Eur J Clin Pharmacol; 2001 Jul; 57(4):285-8. PubMed ID: 11549205
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
[TBL] [Abstract][Full Text] [Related]
6. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
Wright CE; Sisson TL; Fleishaker JC; Antal EJ
J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
[TBL] [Abstract][Full Text] [Related]
8. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
[TBL] [Abstract][Full Text] [Related]
9. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.
Furukori H; Otani K; Yasui N; Kondo T; Kaneko S; Shimoyama R; Ohkubo T; Nagasaki T; Sugawara K
Neuropsychopharmacology; 1998 May; 18(5):364-9. PubMed ID: 9536449
[TBL] [Abstract][Full Text] [Related]
10. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam.
Abernethy DR; Greenblatt DJ; Divoll M; Moschitto LJ; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1983; 80(3):275-8. PubMed ID: 6137021
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
[TBL] [Abstract][Full Text] [Related]
12. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the newer benzodiazepines.
Garzone PD; Kroboth PD
Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.
Wennerholm A; Allqvist A; Svensson JO; Gustafsson LL; Mirghani RA; Bertilsson L
Eur J Clin Pharmacol; 2005 Apr; 61(2):113-8. PubMed ID: 15806426
[TBL] [Abstract][Full Text] [Related]
16. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam.
Yasui N; Kondo T; Furukori H; Kaneko S; Ohkubo T; Uno T; Osanai T; Sugawara K; Otani K
Psychopharmacology (Berl); 2000 Jun; 150(2):185-90. PubMed ID: 10907671
[TBL] [Abstract][Full Text] [Related]
17. Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.
Drabant S; Tóth M; Bereczki A; Bajnógel J; Tömlö J; Klebovich I
Eur J Clin Pharmacol; 2006 Jul; 62(7):587-8. PubMed ID: 16791582
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
Tweedy CM; Milgrom P; Kharasch ED; Kaakko T; Spieker M; Coldwell SE
J Clin Psychopharmacol; 2001 Jun; 21(3):268-72. PubMed ID: 11386489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
